MIT

FDA approves Bionomics’ phase I/II ovarian cancer trial

Monday, March 26, 2012 02:19 PM

Bionomics Limited, an international biotech based in Thebarton, Australia, has gained approval from the FDA to proceed with its clinical trial of BNC105 in women with ovarian cancer.

More... »

GSK invests $794 million in U.K., creates jobs

Friday, March 23, 2012 12:44 PM

GlaxoSmithKline will invest more than $794 million in the U.K. across its manufacturing sites and a new facility in Cumbria to increase production of key active ingredients for its pharmaceutical products and vaccines, creating 1,000 new jobs.

More... »

GSK selects Infosys and Fabric Worldwide to optimize digital strategy

Wednesday, March 21, 2012 10:11 AM

Infosys, a provider of business consulting and technology, engineering and outsourcing services, has formed a partnership with GlaxoSmithKline (GSK), along with Fabric Worldwide, to optimize digital channels across its global consumer healthcare and pharmaceuticals business lines.

More... »

Index Ventures launches $198 million life sciences fund

Wednesday, March 21, 2012 09:26 AM

Index Ventures, a venture capital firm, has launched its first fund solely dedicated to making investments in the life sciences sector.

More... »

GSK launches U.K. apprenticeship program

Wednesday, March 14, 2012 10:37 AM

GlaxoSmithKline (GSK) has launched a new multidisciplinary apprenticeship program aimed at 16- to 24-year-olds, offering positions at the company’s U.K. manufacturing, R&D and corporate sites.

More... »

Dendreon appoints three to executive team

Wednesday, March 14, 2012 09:10 AM

Seattle, Wash.-based Dendreon has appointed three new members to its executive team:

More... »

Dainippon Sumitomo Pharma to acquire Boston Biomedical

Thursday, March 1, 2012 10:54 AM

Dainippon Sumitomo Pharma (DSP) of Osaka, Japan, plans to acquire Norwood, Mass.-based Boston Biomedical (BBI).

More... »

GlaxoSmithKline and Angiochem collaborate on treatments for LSDs

Thursday, March 1, 2012 05:55 AM

Angiochem, a clinical-stage biotechnology company, has partnered with GlaxoSmithKline (GSK) to discover, develop and commercialize treatments for lysosomal storage diseases (LSDs).

More... »

Dr. Stephen Chen named chairman, CEO of Amarillo

Monday, February 27, 2012 10:10 AM

Amarillo Biosciences, a U.S. biotechnology firm, has appointed Dr. Stephen T. Chen CEO and chairman of the board.

More... »

Venn Life Sciences and Encorium to merge

Wednesday, February 22, 2012 01:57 PM

Finland-based CRO Encorium Group and Venn Life Sciences, a provider of development consulting and resourcing services based in Dublin, Ireland, have agreed to merge.

More... »